Gbinigie II and Lasserson D |
Clarithromycin-induced akathisia: a class effect of macrolides? |
2016 |
BMJ Case Rep |
pmid:27927708
|
Miftahussurur M et al. |
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations. |
2016 |
PLoS ONE |
pmid:27906990
|
Velu PP et al. |
Pulmonary Mycobacterium marinum infection: 'fish tank granuloma' of the lung. |
2016 |
Scott Med J |
pmid:27872397
|
Noh HM et al. |
Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice. |
2016 |
Korean J Gastroenterol |
pmid:27871162
|
Noda H et al. |
A Novel Potassium-Competitive Acid Blocker Improves the Efficacy of Clarithromycin-containing 7-day Triple Therapy against Helicobacter pylori. |
2016 |
J Gastrointestin Liver Dis |
pmid:27689190
|
Giorgio F et al. |
Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. |
2016 |
Scand. J. Gastroenterol. |
pmid:27687850
|
Donzelli A |
Helicobacter pylori Eradication? |
2016 |
Gastroenterology |
pmid:27590693
|
Sanches BS et al. |
Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. |
2016 |
World J. Gastroenterol. |
pmid:27672279
|
Cosme A et al. |
Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance. |
2016 |
Helicobacter |
pmid:25982426
|
Luo XF et al. |
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori. |
2016 |
World J. Gastroenterol. |
pmid:27433095
|
Sakurai Y et al. |
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study. |
2016 |
Adv Ther |
pmid:27432383
|
Inagaki K et al. |
Successful Treatment of Peritoneal Dialysis-related Peritonitis due to Mycobacterium iranicum. |
2016 |
Intern. Med. |
pmid:27432106
|
Shiratori S et al. |
Two Cases of Chronic Gastritis with non-Helicobacter pylori Helicobacter Infection. |
2016 |
Intern. Med. |
pmid:27432094
|
Furuta K et al. |
18 Cases of pulmonary Mycobacterium abscessus: Clinical difference depending on the presence or absence of Mycobacterium avium complex. |
2016 |
J. Infect. Chemother. |
pmid:27430867
|
Zemali N et al. |
Helicobacter pylori resistance to clarithromycin in Reunion Island. |
2016 |
Med Mal Infect |
pmid:27427280
|
Ozeki K et al. |
Association of Hay Fever with the Failure of Helicobacter pylori Primary Eradication. |
2016 |
Intern. Med. |
pmid:27374672
|
Hirasawa K et al. |
Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines. |
2016 |
PLoS ONE |
pmid:27977675
|
Mougari F et al. |
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27690688
|
Laird-Fick HS et al. |
Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. |
2016 |
Postgrad Med J |
pmid:27222587
|
Phiphatpatthamaamphan K et al. |
Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study. |
2016 |
Asian Pac. J. Cancer Prev. |
pmid:27221874
|
Kim SY et al. |
Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report. |
2016 |
BMC Infect. Dis. |
pmid:27188784
|
Suzuki S et al. |
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy. |
2016 |
Am. J. Gastroenterol. |
pmid:27185079
|
Garcia de Carvalho NF et al. |
Resazurin Microtiter Assay for Clarithromycin Susceptibility Testing of Clinical Isolates of Mycobacterium abscessus Group. |
2016 |
J. Clin. Lab. Anal. |
pmid:27169515
|
Schuster S et al. |
Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27161641
|
Li M et al. |
Inducible Expression of both ermB and ermT Conferred High Macrolide Resistance in Streptococcus gallolyticus subsp. pasteurianus Isolates in China. |
2016 |
Int J Mol Sci |
pmid:27669217
|
Kawashima K et al. |
Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy. |
2016 |
Dig Liver Dis |
pmid:27012448
|
Ormeci A et al. |
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:27010145
|
Dubini M et al. |
Multiple drug allergy: A case of anaphylaxis to levofloxacin but tolerance to ciprofloxacin. |
2016 |
Ann. Allergy Asthma Immunol. |
pmid:27009438
|
Miyashita N et al. |
Macrolide Therapy for Prevention of Exacerbation in Individuals with Diffuse Aspiration Bronchiolitis. |
2016 |
J Am Geriatr Soc |
pmid:27000351
|
Shichijo S et al. |
Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. |
2016 |
Gastrointest. Endosc. |
pmid:26995689
|
Radzikowska E et al. |
Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment. |
2016 |
Adv. Exp. Med. Biol. |
pmid:26987326
|
Wu DC et al. |
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection. |
2016 |
Medicine (Baltimore) |
pmid:26986096
|
Swaminathan A et al. |
Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications. |
2016 |
Int. J. Tuberc. Lung Dis. |
pmid:26970156
|
Bohnert JA et al. |
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26824939
|
Kadota T et al. |
Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease. |
2016 |
BMC Infect. Dis. |
pmid:26818764
|
Gaüzère BA and Malvy D |
[Vingt-cinquième réunion du comité local de la Société de pathologie exotique, 24 novembre 2015]. |
2016 |
Bull Soc Pathol Exot |
pmid:26818816
|
Tebruegge M et al. |
Nontuberculous Mycobacterial Disease in Children - Epidemiology, Diagnosis & Management at a Tertiary Center. |
2016 |
PLoS ONE |
pmid:26812154
|
Fralick M et al. |
Bleeding associated with coadministration of rivaroxaban and clarithromycin. |
2016 |
CMAJ |
pmid:26811362
|
Berlin S et al. |
Pharmacokinetics and Pulmonary Distribution of Clarithromycin and Rifampicin after Concomitant and Consecutive Administration in Foals. |
2016 |
Mol. Pharm. |
pmid:26808255
|
Sun H et al. |
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014]. |
2016 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:26792053
|
Topp E et al. |
Reduced persistence of the macrolide antibiotics erythromycin, clarithromycin and azithromycin in agricultural soil following several years of exposure in the field. |
2016 |
Sci. Total Environ. |
pmid:27096634
|
Li X et al. |
Macrolides use and the risk of sudden cardiac death. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27086751
|
Boyanova L et al. |
Clarithromycin Resistance Mutations in Helicobacter pylori in Association with Virulence Factors and Antibiotic Susceptibility of the Strains. |
2016 |
Microb. Drug Resist. |
pmid:26618567
|
Villain J et al. |
Acute toxicities of pharmaceuticals toward green algae. mode of action, biopharmaceutical drug disposition classification system and quantile regression models. |
2016 |
Ecotoxicol. Environ. Saf. |
pmid:26590695
|
Geng S et al. |
Clarithromycin ion pair in a liposomal membrane to improve its stability and reduce its irritation caused by intravenous administration. |
2016 |
Expert Opin Drug Deliv |
pmid:26588710
|
Shin WG et al. |
Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide Survey. |
2016 |
Helicobacter |
pmid:26470999
|
Cerqueira RM et al. |
How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery? |
2016 |
Obes Surg |
pmid:26467690
|
Boyanova L et al. |
Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria. |
2016 |
Infect Dis (Lond) |
pmid:26465202
|
Lahmer T et al. |
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS. |
2016 |
Mycopathologia |
pmid:26455910
|
Liou JM et al. |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of in the community and hospital populations: a randomised trial. |
2016 |
Gut |
pmid:26338825
|